{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:48:17Z","timestamp":1781880497058,"version":"3.54.5"},"reference-count":50,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jtocrr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JTO Clinical and Research Reports"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jtocrr.2022.100429","type":"journal-article","created":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T17:49:09Z","timestamp":1667756949000},"page":"100429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Utilization and Outcomes of Radiation in Stage IV Esophageal Cancer"],"prefix":"10.1016","volume":"3","author":[{"given":"Peter Lee","family":"Zhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen E.","family":"Canavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Ermer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Pichert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew X.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.","family":"Maduka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly L.","family":"Johung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5471-8833","authenticated-orcid":false,"given":"Daniel J.","family":"Boffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtocrr.2022.100429_bib1","first-page":"85","article-title":"Esophageal cancer chemotherapy: recent advances","volume":"2","author":"Ilson","year":"2008","journal-title":"Gastrointest Cancer Res"},{"key":"10.1016\/j.jtocrr.2022.100429_bib2","unstructured":"American Cancer Society. Survival rates for esophageal cancer. https:\/\/www.cancer.org\/cancer\/esophagus-cancer\/detection-diagnosis-staging\/survival-rates.html. Accessed October 19, 2022."},{"key":"10.1016\/j.jtocrr.2022.100429_bib3","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: esophageal and esophagogastric junction cancers. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/esophageal.pdf. Accessed October 19, 2022."},{"key":"10.1016\/j.jtocrr.2022.100429_bib4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.prro.2011.12.002","article-title":"Palliative radiotherapy in patients with esophageal carcinoma: a retrospective review","volume":"2","author":"Murray","year":"2012","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.jtocrr.2022.100429_bib5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/pro6.1119","article-title":"Guidelines for radiotherapy of esophageal carcinoma (2020 edition)","volume":"5","author":"Gong","year":"2021","journal-title":"Precis Radiat Oncol"},{"key":"10.1016\/j.jtocrr.2022.100429_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/dote\/dow033","article-title":"Clinical outcomes of definitive chemoradiotherapy using carboplatin and paclitaxel in esophageal cancer","volume":"30","author":"van Ruler","year":"2017","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.jtocrr.2022.100429_bib7","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1442-2050.2004.00420.x","article-title":"Chemoradiation therapy is effective for the palliative treatment of malignant dysphagia","volume":"17","author":"Harvey","year":"2004","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.jtocrr.2022.100429_bib8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13014-021-01880-9","article-title":"Short-course compared to long-course palliative radiotherapy for oesophageal cancer: a single centre observational cohort study","volume":"16","author":"Olafsdottir","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.jtocrr.2022.100429_bib9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.gie.2018.04.2362","article-title":"Liquid nitrogen spray cryotherapy for dysphagia palliation in patients with inoperable esophageal cancer","volume":"88","author":"Kachaamy","year":"2018","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jtocrr.2022.100429_bib10","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1001\/jamaoncol.2016.6905","article-title":"Using the national cancer database for outcomes research: a review","volume":"3","author":"Boffa","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jtocrr.2022.100429_bib11","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1245\/s10434-019-07323-w","volume":"26","author":"Shulman","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jtocrr.2022.100429_bib12","unstructured":"American College of Surgeons. National cancer database participant user file. https:\/\/www.facs.org\/-\/media\/files\/quality-programs\/cancer\/ncdb\/puf_data_dictionary.ashx. Accessed October 19, 2022."},{"key":"10.1016\/j.jtocrr.2022.100429_bib13","first-page":"24","article-title":"Effectiveness of several external beam radiotherapy schedules for palliation of esophageal cancer","volume":"17","author":"Walterbos","year":"2019","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.jtocrr.2022.100429_bib14","first-page":"125","article-title":"Survival and symptom relief after palliative radiotherapy for esophageal cancer","volume":"7","author":"Welsch","year":"2016","journal-title":"J\u00a0Cancer"},{"key":"10.1016\/j.jtocrr.2022.100429_bib15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s12262-013-0817-4","article-title":"Palliative radiotherapy in esophageal cancer","volume":"77","author":"Prasad","year":"2015","journal-title":"Indian J Surg"},{"key":"10.1016\/j.jtocrr.2022.100429_bib16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.clon.2007.10.003","article-title":"A\u00a0phase I\/II study to evaluate the toxicity and efficacy of accelerated fractionation radiotherapy for the palliation of dysphagia from carcinoma of the oesophagus","volume":"20","author":"Kassam","year":"2008","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.jtocrr.2022.100429_bib17","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.17581","article-title":"Association of insurance status and extent of organ involvement with survival among patients with stage IV cancer","volume":"5","author":"Zhan","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jtocrr.2022.100429_bib18","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1245\/s10434-020-09080-7","article-title":"Where the other half dies: analysis of mortalities occurring more than 30 days after complex cancer surgery","volume":"28","author":"Resio","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jtocrr.2022.100429_bib19","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2147\/CMAR.S150350","article-title":"Sites of metastasis and overall survival in esophageal cancer: a population-based study","volume":"9","author":"Wu","year":"2017","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.jtocrr.2022.100429_bib20","doi-asserted-by":"crossref","first-page":"5954","DOI":"10.21037\/apm-20-1128","article-title":"Oligometastatic breast cancer: where are we now and where are we headed? -a\u00a0narrative review","volume":"10","author":"Kent","year":"2021","journal-title":"Ann Palliat Med"},{"key":"10.1016\/j.jtocrr.2022.100429_bib21","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1186\/s12885-019-6448-9","article-title":"Proposal for a definition of \u201cOligometastatic disease in pancreatic cancer\u201d.","volume":"19","author":"Damanakis","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jtocrr.2022.100429_bib22","unstructured":"American College of Surgeons. National cancer database participant user file 2019 data dictionary. https:\/\/www.facs.org\/media\/aq3aummh\/puf_data_dictionary_2019.pdf. Accessed October 10, 2022."},{"key":"10.1016\/j.jtocrr.2022.100429_bib23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals","volume":"81","author":"Grambsch","year":"1994","journal-title":"Biometrika"},{"key":"10.1016\/j.jtocrr.2022.100429_bib24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.21037\/aoe-2020-08","article-title":"Palliation of malignant dysphagia: stent or radiotherapy?","volume":"4","author":"Koggel","year":"2021","journal-title":"Ann Esophagus"},{"key":"10.1016\/j.jtocrr.2022.100429_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12029-010-9206-4","article-title":"Palliative stenting with or without radiotherapy for inoperable esophageal carcinoma: a randomized trial","volume":"43","author":"Javed","year":"2012","journal-title":"J\u00a0Gastrointest Cancer"},{"key":"10.1016\/j.jtocrr.2022.100429_bib26","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1002\/sim.2836","article-title":"Parametric survival analysis and taxonomy of hazard functions for the generalized gamma distribution","volume":"26","author":"Cox","year":"2007","journal-title":"Stat Med"},{"key":"10.1016\/j.jtocrr.2022.100429_bib27","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.21037\/tcr.2019.06.15","article-title":"Survival benefit of radiotherapy in metastatic esophageal cancer: a population-based study","volume":"8","author":"Li","year":"2019","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.jtocrr.2022.100429_bib28","doi-asserted-by":"crossref","first-page":"E1026","DOI":"10.9778\/cmajo.20200306","article-title":"Structures, processes and models of care for emergency general surgery in Ontario: a cross-sectional survey","volume":"9","author":"Skelhorne-Gross","year":"2021","journal-title":"CMAJ Open"},{"key":"10.1016\/j.jtocrr.2022.100429_bib29","doi-asserted-by":"crossref","first-page":"iii29","DOI":"10.1093\/annonc\/mdx261.060","article-title":"Role of palliative radiotherapy, chemotherapy and stents for dysphagia and quality of life improvement in advanced esophageal cancer. The optimal management?","volume":"28","author":"Bhatnagar","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtocrr.2022.100429_bib30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s13014-018-1183-y","article-title":"Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for stage IV esophageal squamous cell carcinoma: a retrospective controlled study","volume":"13","author":"Lyu","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.jtocrr.2022.100429_bib31","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ijrobp.2015.11.043","article-title":"Improving outcomes for esophageal cancer using proton beam therapy","volume":"95","author":"Chuong","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jtocrr.2022.100429_bib32","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1111\/j.1572-0241.2001.03923.x","article-title":"A\u00a0prospective, randomized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction","volume":"96","author":"Vakil","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jtocrr.2022.100429_bib33","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.3747\/co.19.892","article-title":"What is the optimal management of dysphagia in metastatic esophageal cancer?","volume":"19","author":"Hanna","year":"2012","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jtocrr.2022.100429_bib34","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S0140-6736(04)17272-3","article-title":"Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial","volume":"364","author":"Homs","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jtocrr.2022.100429_bib35","doi-asserted-by":"crossref","first-page":"e1537","DOI":"10.1200\/OP.20.00397","article-title":"First-line palliative chemotherapy for esophageal and gastric cancer: practice patterns and outcomes in the general population","volume":"17","author":"Merchant","year":"2021","journal-title":"JCO Oncol Pract"},{"key":"10.1016\/j.jtocrr.2022.100429_bib36","first-page":"2705","article-title":"Palliative chemotherapy for recurrent and metastatic esophageal cancer","volume":"27","author":"Grunberger","year":"2007","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jtocrr.2022.100429_bib37","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1200\/JCO.2002.09.029","article-title":"Multicenter randomized phase III trial comparing protracted venous infusion (PVI) fluorouracil (5-FU) with PVI 5-FU plus mitomycin in inoperable pancreatic cancer","volume":"20","author":"Maisey","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtocrr.2022.100429_bib38","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/annonc\/mdf273","article-title":"A\u00a0multicentre, randomised phase III trial comparing protracted venous infusion (PVI) 5-fluorouracil (5-FU) with PVI 5-FU plus Mitomycin C in patients with inoperable oesophago-gastric cancer","volume":"13","author":"Tebbutt","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtocrr.2022.100429_bib39","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/doab051","article-title":"Spray cryotherapy prevents need for palliative stenting in patients with esophageal cancer-associated dysphagia","volume":"35","author":"Hanada","year":"2022","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.jtocrr.2022.100429_bib40","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.3748\/wjg.v24.i43.4862","article-title":"Cryotherapy in the management of premalignant and malignant conditions of the esophagus","volume":"24","author":"Lal","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jtocrr.2022.100429_bib41","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/den.13353","article-title":"Role of photodynamic therapy in the treatment of esophageal cancer","volume":"31","author":"Wu","year":"2019","journal-title":"Dig Endosc"},{"key":"10.1016\/j.jtocrr.2022.100429_bib42","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.suc.2019.02.007","article-title":"Palliative management of gastric and esophageal cancer","volume":"99","author":"Halpern","year":"2019","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.jtocrr.2022.100429_bib43","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/lsm.20364","article-title":"Role of photodynamic therapy in unresectable esophageal and lung cancer","volume":"38","author":"Chen","year":"2006","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.jtocrr.2022.100429_bib44","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/153303460300200108","article-title":"Photodynamic therapy for esophageal cancer: a useful and realistic option","volume":"2","author":"Barr","year":"2003","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.jtocrr.2022.100429_bib45","doi-asserted-by":"crossref","first-page":"CR323","DOI":"10.12659\/MSM.882739","article-title":"The evaluation of esophageal stenting complications in palliative treatment of dysphagia related to esophageal cancer","volume":"18","author":"Kujawski","year":"2012","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jtocrr.2022.100429_bib46","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.jtho.2017.03.026","article-title":"Improved overall survival with aggressive primary tumor radiotherapy for patients with metastatic esophageal cancer","volume":"12","author":"Guttmann","year":"2017","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2022.100429_bib47","first-page":"E138","article-title":"Definitive radiation therapy for patients with metastatic esophageal squamous cell carcinoma improves survival: an NCDB analysis","volume":"99","author":"Berriochoa","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"suppl","key":"10.1016\/j.jtocrr.2022.100429_bib48","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ijrobp.2016.06.020","article-title":"Prospective randomized phase 2 study of concurrent chemoradiation therapy (CCRT) versus chemotherapy alone in stage IV esophageal squamous cell carcinoma (ESCC)","volume":"96","author":"Li","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jtocrr.2022.100429_bib49","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1200\/JCO.2002.20.5.1167","article-title":"INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy","volume":"20","author":"Minsky","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtocrr.2022.100429_bib50","series-title":"Modern Epidemiology","author":"Rothman","year":"1998"}],"container-title":["JTO Clinical and Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666364322001539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666364322001539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:38:23Z","timestamp":1762987103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666364322001539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2666364322001539"],"URL":"https:\/\/doi.org\/10.1016\/j.jtocrr.2022.100429","relation":{},"ISSN":["2666-3643"],"issn-type":[{"value":"2666-3643","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utilization and Outcomes of Radiation in Stage IV Esophageal Cancer","name":"articletitle","label":"Article Title"},{"value":"JTO Clinical and Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtocrr.2022.100429","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc. on behalf of the International Association for the Study of Lung Cancer.","name":"copyright","label":"Copyright"}],"article-number":"100429"}}